UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000008465
Receipt No. R000009814
Scientific Title PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancer
Date of disclosure of the study information 2012/07/18
Last modified on 2018/07/13 10:20:24

No. Disposal Last modified on Item of update
1 Insert 2012/07/18 15:15:14
2 Update 2014/01/18 19:34:05 TEL
Email
Address
Address
TEL
Email
Email
3 Update 2018/07/13 10:09:57 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
4 Update 2018/07/13 10:17:28 Division name
Division name
Address
Email
Division name
Division name
Address
Email
Division name
Division name
Address
Email
Name of primary sponsor
Organization
Email1
5 Update 2018/07/13 10:20:24 Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria


Contact us.